Earlier this year I had the opportunity to participate in a panel discussion about AI and biosecurity at the annual SynBioBeta meeting. Those of us closest to this issue, including my colleagues and I at Ansa, feel a great sense of urgency about improving biosecurity practices for DNA synthesis. The prominence of this topic at the conference was a good…
We didn’t start off as DNA synthesis technology developers; we started off as customers. We were stunned to learn how difficult it was to acquire the DNA we needed for our experiments — and when we traced the problems back to their roots, most of them stemmed from the chemical synthesis approach…
When MIT scientists Drew Endy, Tom Knight, and Randy Rettberg held a month-long biological engineering program back in 2003, they probably never imagined that it would pave the way for the iGEM annual synthetic biology competition that has been going strong for more than two decades.
Today, we are proud to announce the commercial availability of our high-quality clonal DNA products as long as 50 kb — almost 100-fold the size of where we began! Unlock new possibilities with 50 kb clonal DNA from Ansa.
If your research depends on DNA, you know the frustration: sliding timelines, added fees, and the email no one wants to read — ‘One or more of your sequences failed synthesis…’
When you work with synthetic DNA, a lot of care goes into the sequences you design. But what happens when you’ve got your sequences ready and it’s time to place an order?
As costs fall, the question shifts from “What can we afford?” to “What can we imagine?”
The Ansa team was thrilled to participate in this year’s Global Synthetic Biology conference, better known to the community as SynBioBeta. It’s the leading annual event for the synthetic biology field, but for us, it has a more personal connection…
Whether it’s for constructing transgene payloads or engineering viral vector delivery systems, researchers count on gene synthesis vendors throughout the discovery, development, and manufacturing journey.
Today, we announced a transformation in our business model. Our new Ansa On-Time Guarantee shifts us from best-effort fulfillment to a bold, reliability-first approach — one that we hope will catalyze change across the entire DNA synthesis field.